Literature DB >> 15718004

[Pulmonary manifestations of inflammatory bowel disease].

M C Vennera1, C Picado.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15718004     DOI： 10.1016/s1579-2129(06)60404-7

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  4 in total

1.  Sulfasalazine-Induced Interstitial Fibrosis.

Authors:  Bugra Kerget; Omer Araz; Elif Yilmazel Ucar; Ozkan Aydin; Metin Akgun; Leyla Saglam
Journal:  Eurasian J Med       Date:  2018-10

Review 2.  [Aspects of pulmonary involvement in inflammatory bowel disease].

Authors:  A Moeser; M Lerche; H Wirtz; A Stallmach
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

Review 3.  Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.

Authors:  Roberta Caccaro; Edoardo Savarino; Renata D'Incà; Giacomo Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 4.  Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines.

Authors:  Peng-De Lu; Yong-Hua Zhao
Journal:  Chin Med       Date:  2020-02-10       Impact factor: 5.455
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.